Brexit Preparations

or call +44 1624 672777

The UK officially left the European Union on January 31st and has now entered a ‘transition period’ until the end of 2020.

If you are based in the UK, hold an MA in the UK, or have your EU QPPV in the UK, you will be affected.

At Panacea, we’ve kept track of the evolving Brexit landscape and can offer a range of services to help you prepare for the impending changes and manage the transition.

How Panacea can help…

We have offices in the UK, Ireland and the Isle of Man and are well placed to help you to prepare for and implement the changes that may be required due to Brexit.

The services that we offer include:

  • Practical guidance on the regulatory and pharmacovigilance actions required in the case of a ‘deal’ or ‘no-deal’ scenario
  • EU QPPV services (non-UK based)
  • Pharmacovigilance System Master File (PSMF) and backup services located in the EU
  • Preparation and submission of Brexit-related variations, including the required updates to Product Information
  • Preparation and submission of MA transfers
  • UK QPPV services
  • Acting as local (UK-based) contact for the MHRA

Please contact us to find out how we can help you.

Panacea Webinar: “The Impact of Brexit on Pharmacovigilance”

Panacea’s Brexit expert Elena Snidal has prepared the below webinar on the impact of Brexit on pharmacovigilance, including top tips to ensure preparedness.

If you would like any further information or support with the implementation of pharmacovigilance-related Brexit changes within your company, please contact us by telephone +44 1624 672777 or email info@panacea.im

or call +44 1624 672777